Method for preparing virosomes
This disclosure relates to methods for preparing a virosome preparation comprising viral envelope protein of at least two, preferably at least three, more preferably at least four, different enveloped viruses, as well as to virosomal preparations obtained thereby. The disclosure also relates to the use of the virosomal preparations, e.g., as a vaccine.
1 . A method for preparing a virosome preparation comprising viral envelope protein of at least two different enveloped viruses, the method comprising:
solubilizing at least two viral envelopes by adding a solubilizing agent; and
reconstituting virosomal membranes comprising viral envelope protein of said at least two different viruses by removing the solubilizing agent,
wherein the viral envelopes of said at least two different virus are blended prior to reconstitution of the virosomal membranes.
2 . The method according to claim 1 , wherein the viral envelopes preferably are blended prior to inactivation of the at least two viral envelopes.
3 . The method according to claim 1 , wherein the viral envelopes are blended prior to solubilizing the viral envelopes.
4 . The method according to claim 1 , wherein the viral envelopes are blended after solubilizing the viral envelopes.
5 . The method according to claim 1 , wherein the at least preferably two viral envelopes comprise at least two different virus strains of an enveloped virus.
6 . The method according to claim 5 , wherein the enveloped virus is an influenza virus and the viral envelope protein is hemagglutinin (HA) and/or neuraminidase (NA).
7 . The method according to claim 1 , further comprising:
one or more exogenous components to the solubilized viral envelopes.
8 . A virosome preparation produced by the method of claim 1 .
9 . A virosome having a virosomal membrane comprising:
viral envelope of at least two different enveloped viruses.
10 . The virosome according to claim 9 , wherein the at least two different enveloped viruses comprise at least two different virus strains of an enveloped virus.
11 . The virosome according to claim 9 , wherein the enveloped virus is an influenza virus and the viral envelope protein is HA and/or neuraminidase (NA).
12 . The virosome according to claim 9 , further comprising:
one or more antigens incorporated and/or linked to the virosomal membrane.
13 . A composition comprising:
the virosome preparation according to claim 8 .
14 . A composition comprising:
the virosome according to claim 9 .
15 . A vaccine comprising:
an amount of the composition according to claim 13 for use as a vaccine.
16 . An immunogenic composition comprising:
an amount of the composition according to claim 13 for use as an adjuvant.
17 . The composition according to claim 14 , which is therapeutic.
18 . A targeting ligand comprising:
the composition according to claim 13 for use as targeting ligand.
19 . The method according to claim 1 , wherein:
the virosome preparation comprises viral envelope protein of at least three different enveloped viruses; and
at least three viral envelopes are solubilized by adding a solubilizing agent.
20 . The method according to claim 19 , wherein:
the virosome preparation comprises viral envelope protein of at least four different enveloped viruses; and
at least four viral envelopes are solubilized by adding a solubilizing agent.
21 . The method according to claim 1 , further comprising:
inactivating the enveloped viruses.
22 . The virosome of claim 9 , having a virosomal membrane comprising:
viral envelope protein of at least three different enveloped viruses.
23 . The virosome of claim 22 , having a virosomal membrane comprising:
viral envelope protein of at least four different enveloped viruses.
24 . The virosome of claim 22 , wherein the at least three different enveloped viruses comprise at least three different virus strains of an enveloped virus.
25 . The virosome of claim 23 , wherein the at least four different enveloped viruses comprise at least four different virus strains of an enveloped virus.